|
Delayed
NSE India S.E.
13:40:41 13/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,459.60 INR | -0.23% |
|
-1.08% | -3.32% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.48x | 3.15x | 4.05x | 3.47x | 17.99x | 23.06x | 0.89% | 12.39B | |
| 35.87x | 5.03x | 2.68x | 6.74x | 23.34x | 28.23x | 0.88% | 48.9B | |
| 19.3x | 1.97x | -2.63x | 2.27x | 10.33x | 13.46x | 1.34% | 40.42B | |
| 29.03x | 3.98x | -1.69x | 4.11x | 16.91x | 23.69x | 0.58% | 12.6B | |
| 18.7x | 3.24x | 3.7x | 3.32x | 11.56x | 13.77x | 3.86% | 9.07B | |
| 9.13x | 1.57x | 0.75x | 2.11x | 5.49x | 6.77x | 4.41% | 7.53B | |
| 15.9x | 1.29x | 6.87x | 2.06x | 6.43x | 9.68x | 3.24% | 7.13B | |
| 34.76x | 6.15x | 0.45x | 3.96x | 16.87x | 18.63x | 0.23% | 6.78B | |
| 42.23x | 9.71x | 3.01x | 8.1x | 30.02x | 33.52x | 0.94% | 4.64B | |
| 14.76x | 0.72x | -0.03x | 2.06x | 8.81x | 11.14x | 1.83% | 4B | |
| 15.78x | 2.58x | 0.68x | 2.55x | 11.87x | 11.51x | 3.37% | 4B | |
| 14.79x | 2.98x | 1.23x | 3.44x | 12.86x | 14.21x | 2.68% | 2.94B | |
| 12.71x | - | 3.15x | 10.18x | 9.46x | 9.69x | - | 2.74B | |
| 19.03x | 5.1x | 1.56x | 5.93x | 16.86x | 18.24x | 3.16% | 2.64B | |
| 31.99x | - | -0.13x | - | - | - | - | 2.47B | |
| Average | 22.83x | 3.65x | 1.58x | 4.31x | 14.20x | 16.83x | 2.11% | 11.22B | |
| Weighted average by Cap. | 25.95x | 3.60x | 1.06x | 4.30x | 15.87x | 19.56x | 1.53% |
- Stock Market
- Stocks
- CIPLA Stock
- Sector Cipla Limited
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
